Department of Pathology, University College of Medical Sciences, Delhi, India.
Department of Pediatrics, All India Institute of Medical Sciences, Delhi, India.
Forensic Sci Med Pathol. 2022 Dec;18(4):516-529. doi: 10.1007/s12024-022-00502-4. Epub 2022 Sep 1.
Clinical features of COVID-19 range from mild respiratory symptoms to fatal outcomes. Autopsy findings are important for understanding COVID-19-related pathophysiology and clinical manifestations. This systematic study aims to evaluate autopsy findings in paediatric cases. We searched PubMed, EMBASE, and Cochrane Database Reviews. We included studies that reported autopsy findings in children with COVID-19. A total of 11 studies (24 subjects) were included. The mean age of patients was 5.9 ± 5.7 years. Grossly, there was pericardial and pleural effusion, hepatosplenomegaly, cardiomegaly, heavy soft lung, enlarged kidney, and enlarged brain. The autopsy findings of the lungs were diffuse alveolar damage (78.3%), fibrin thrombi (43.5%), haemorrhage (30.4%), pneumonia (26%), congestion and oedema (26%), angiomatoid pattern (17.4%), and alveolar megakaryocytes (17.4%). The heart showed interstitial oedema (80%), myocardial foci of band necrosis (60%), fibrin microthrombi (60%), interstitial and perivascular inflammation (40%), and pancarditis (30%). The liver showed centrilobular congestion (60%), micro/macrovesicular steatosis (30%), and arterial/venous thrombi (20%). The kidney showed acute tubular necrosis (75%), congestion (62.5%), fibrin thrombi in glomerular capillaries (37.5%), and nephrocalcinosis, mesangial cell hyperplasia, tubular hyaline/granular casts (25% each). The spleen showed splenitis (71.4%), haemorrhage (71.4%), lymphoid hypoplasia (57.1%), and haemophagocytosis (28.6%). The brain revealed oedema (87.5%), congestion (75%), reactive microglia (62.5%), neuronal ischaemic necrosis (62.5%), meningoencephalitis (37.5%), and fibrin thrombi (25%). SARS-CoV-2 and CD68 were positive by immunohistochemistry in 85.7% and 33.3% cases, respectively. Autopsy findings of COVID-19 in children are variable in all important organs. It may help in better understanding the pathogenesis of SARS-CoV-2.
COVID-19 的临床特征从轻微的呼吸道症状到致命的结果不等。尸检结果对于了解 COVID-19 相关的病理生理学和临床表现非常重要。本系统研究旨在评估儿科病例的尸检结果。我们搜索了 PubMed、EMBASE 和 Cochrane Database Reviews。我们纳入了报道 COVID-19 患儿尸检结果的研究。共纳入 11 项研究(24 例患者)。患者的平均年龄为 5.9±5.7 岁。大体上,有心包和胸腔积液、肝脾肿大、心脏增大、肺湿重、肾脏增大和大脑增大。肺的尸检结果为弥漫性肺泡损伤(78.3%)、纤维蛋白血栓(43.5%)、出血(30.4%)、肺炎(26%)、充血和水肿(26%)、血管母细胞瘤样模式(17.4%)和肺泡巨核细胞(17.4%)。心脏显示间质水肿(80%)、心肌局灶性带状坏死(60%)、纤维蛋白微血栓(60%)、间质和血管周围炎症(40%)和全心炎(30%)。肝脏显示中央静脉充血(60%)、微/大泡性脂肪变性(30%)和动静脉血栓形成(20%)。肾脏显示急性肾小管坏死(75%)、充血(62.5%)、肾小球毛细血管纤维蛋白血栓(37.5%)、肾钙质沉着症、系膜细胞增生、肾小管透明/颗粒状铸型(各 25%)。脾脏显示脾炎(71.4%)、出血(71.4%)、淋巴组织发育不良(57.1%)和噬血细胞现象(28.6%)。大脑显示水肿(87.5%)、充血(75%)、反应性小胶质细胞(62.5%)、神经元缺血性坏死(62.5%)、脑膜脑炎(37.5%)和纤维蛋白血栓(25%)。SARS-CoV-2 和 CD68 的免疫组织化学检测阳性率分别为 85.7%和 33.3%。儿童 COVID-19 的尸检结果在所有重要器官中均存在差异。这可能有助于更好地了解 SARS-CoV-2 的发病机制。